State Street Discloses Passive Stake in Replimune Group
Ticker: REPL · Form: SC 13G · Filed: Jan 25, 2024 · CIK: 1737953
| Field | Detail |
|---|---|
| Company | Replimune Group, Inc. (REPL) |
| Form Type | SC 13G |
| Filed Date | Jan 25, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, passive-investment, SC-13G
TL;DR
**State Street just reported a passive stake in Replimune, signaling institutional confidence.**
AI Summary
State Street Corporation, a major financial institution, filed an SC 13G on January 25, 2024, disclosing its ownership of common stock in Replimune Group, Inc. as of December 31, 2023. This filing indicates that State Street holds a significant, but passive, stake in Replimune, meaning they are not seeking to influence management. This matters to investors because large institutional holdings like this can signal confidence in the company's long-term prospects and provide a degree of stability to the stock.
Why It Matters
This filing shows a major institutional investor, State Street Corporation, has a significant, passive stake in Replimune Group, Inc., which can be seen as a vote of confidence in the company's future.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of passive ownership by a large institution, which generally does not introduce new risks.
Analyst Insight
A smart investor would note State Street's passive stake as a potential indicator of institutional confidence in Replimune Group, Inc., but would also conduct further due diligence on Replimune's fundamentals and future prospects before making any investment decisions.
Key Players & Entities
- State Street Corporation (company) — the reporting person and institutional investor
- Replimune Group, Inc. (company) — the subject company whose securities are being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- January 25, 2024 (date) — the filing date of the SC 13G
FAQ
What type of filing is this and what does it generally indicate?
This is an SC 13G filing, which is typically used by passive investors who own more than 5% but less than 20% of a company's stock and do not intend to influence or control the company's management or policies. It signals a significant, but non-activist, ownership stake.
Who is the reporting person in this SC 13G filing?
The reporting person is State Street Corporation, a financial institution with IRS Identification No. 04-2456637, incorporated in Massachusetts.
Which company's securities are the subject of this filing?
The subject company is Replimune Group, Inc., a company in the biological products industry (SIC 2836), with CIK 0001737953.
What was the date of the event that triggered this filing?
The date of the event which required the filing of this statement was December 31, 2023, as stated on the cover page of the filing.
Under which rule was this Schedule 13G filed?
This Schedule 13G was filed under Rule 13D-1 (B), as indicated by the 'X' in the appropriate box on the cover page.
Filing Details
This Form SC 13G (Form SC 13G) was filed with the SEC on January 25, 2024 regarding Replimune Group, Inc. (REPL).